Cisplatin versus non-cisplatin based first-line chemotherapy for advanced urothelial carcinoma previously treated with peri-operative cisplatin

INTRODUCTION: The optimal choice of first-line chemotherapy in urothelial carcinoma (UC) patients who relapse after receiving peri-operative cisplatin-based chemotherapy (PCBC) is unclear. We investigated outcomes with cisplatin re-challenge vs. a non-cisplatin regimen in patients with recurrent met...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Genitourin Cancer
Autores principales: Locke, Jennifer A, Pond, Gregory Russell, Sonpavde, Guru, Necchi, Andrea, Giannatempo, Patrizia, Paluri, Ravi Kumar, Niegisch, Guenter, Albers, Peter, Buonerba, Carlo, di Lorenzo, Giuseppe, Vaishampayan, Ulka N., North, Scott A., Agarwal, Neeraj, Hussain, Syed A., Eigl, Bernhard J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913522/
https://ncbi.nlm.nih.gov/pubmed/26589729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.10.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares